← Back to Search

Behavioural Intervention

Educate and Engage for Chronic Kidney Disease (ExPAND Trial)

N/A

Waitlist Available

Research Sponsored by George Washington University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Person with CKD, cared for at participating clinic:

Age 65 years or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up starts after consent to participate in longitudinal interviews. repeats every 4 months until first of project completion or patient death, assessed up to 40 months.

Awards & highlights

ExPAND Trial Summary

This trial aims to compare two different approaches in how kidney failure treatment options are presented to older patients. The first approach focuses on educating patients about all available treatment choices, including alternative options, and engaging them

Who is the study for?

This trial is for older patients with kidney failure who are exploring treatment options. Participants should be willing to engage in educational programs about kidney disease, use decision aids, and participate in shared decision-making processes.Check my eligibility

What is being tested?

The study compares two approaches: 'Educate and Engage' which involves education and shared decision-making support, versus 'Educate and Engage Plus Kidney Supportive Care Program' that adds palliative care support for those choosing alternative treatments.See study design

What are the potential side effects?

Since this trial focuses on educational interventions and supportive care rather than medications or invasive procedures, traditional side effects are not a concern. However, emotional or psychological impacts may arise from discussing end-of-life choices.

ExPAND Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have chronic kidney disease and am treated at a participating clinic.

Select...

I am 65 years old or older.

ExPAND Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ starts after consent to participate in longitudinal interviews. repeats every 4 months until first of project completion or patient death, assessed up to 40 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~starts after consent to participate in longitudinal interviews. repeats every 4 months until first of project completion or patient death, assessed up to 40 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and starts after consent to participate in longitudinal interviews. repeats every 4 months until first of project completion or patient death, assessed up to 40 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Decisional Conflict Scale score

Proportion of patients choosing Alternative Treatment Plans (ATP)

Secondary outcome measures

AMCWD & DND patients who initiate dialysis in the last month of life

Advance care planning (ACP) documentation

CollaboRATE score

+11 more

Other outcome measures

ATP patient reports of experience of ATP care (qualitative)

Acceptability (Organizational)

Appropriateness (Organizational)

+12 more

ExPAND Trial Design

2Treatment groups

Experimental Treatment

Group I: Educate and Engage Plus Kidney Supportive Care ProgramExperimental Treatment1 Intervention

Patients accrued and making treatment decisions while the clinic treating them is implementing Approach 2.

Group II: Educate and EngageExperimental Treatment1 Intervention

Patients accrued and making treatment decisions while the clinic treating them is implementing Approach 1.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

George Washington UniversityLead Sponsor

243 Previous Clinical Trials

450,774 Total Patients Enrolled

Patient-Centered Outcomes Research InstituteOTHER

550 Previous Clinical Trials

29,993,948 Total Patients Enrolled

West Virginia University Research CorporationUNKNOWN

1 Previous Clinical Trials

476 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In how many distinct clinics is this experimental investigation currently being conducted?

"At present, this clinical study is operational at 6 sites including Morgantown, Peoria, and Jefferson alongside other cities. Opting for the nearest site can reduce travel burden if you decide to take part."

Answered by AI

Are there any available slots for patients to participate in this clinical trial?

"As per clinicaltrials.gov, this particular research endeavor is currently not open for recruitment. This study was first listed on September 1st, 2024 and most recently updated on January 26th, 2024. Despite its closure to new participants, there are a total of 507 active trials seeking eligible individuals at the moment."

Answered by AI

Recent research and studies

Patient Education and CounselingJournal

Developing Collaborate: A Fast and Frugal Patient-reported Measure of Shared Decision Making in Clinical Encounters

Elwyn, Glyn, Paul James Barr, Stuart W. Grande, Rachel Thompson, Thom Walsh, and Elissa M. Ozanne. 2013. “Developing Collaborate: A Fast and Frugal Patient-reported Measure of Shared Decision Making in Clinical Encounters”. Patient Education and Counseling. Elsevier BV. doi:10.1016/j.pec.2013.05.009.

Administration and Policy in Mental Health and Mental Health Services ResearchJournal

Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda

Proctor, Enola, Hiie Silmere, Ramesh Raghavan, Peter Hovmand, Greg Aarons, Alicia Bunger, Richard Griffey, and Melissa Hensley. 2010. “Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda”. Administration and Policy in Mental Health and Mental Health Services Research. Springer Science and Business Media LLC. doi:10.1007/s10488-010-0319-7.

clinicaltrials.govStudy

Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial

2024. "Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06243068.